The London Regional Transgenic & Gene Targeting Facility (LRTGT) was established in 2003 as a collaborative endeavor between The University of Western Ontario, Lawson Health Research Institute, Robarts Research Institute and the London Regional Cancer Program.  The LRTGT provides services to generate genetically modified mice through pronuclear injection and gene targeting in ES cells.  For London based researchers, we also rederive and cryopreserve lines for distribution.  Towards this end

the LRTGT is establishing a mouse

embryo bank to enhance

collaborations for researchers

locally, nationally, and

internationally.